Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Peerj|March 29, 2017
Systematic drug repositioning through mining adverse event data in ClinicalTrials.govEric Wen Su, Todd M SangerStatistics in Medicine|March 10, 2006
Estimating the response rate in the presence of measurement errorYongming Qu, Pandurang M Kulkarni, Todd M SangerDepression and Anxiety|May 20, 2006
A randomized, double-blind comparison of olanzapine/fluoxetine combination, olanzapine, fluoxetine, and venlafaxine in treatment-resistant depressionSara A Corya, Doug Williamson, Todd M Sanger, et al.Journal of Affective Disorders|July 10, 2002
Economic, clinical, and quality-of-life outcomes associated with olanzapine treatment in mania. Results from a randomized controlled trialMadhav A Namjoshi, Gopalan Rajamannar, Thomas Jacobs, et al.The Journal of Clinical Psychiatry|March 6, 2007
A randomized, double-blind comparison of olanzapine/fluoxetine combination, olanzapine, and fluoxetine in treatment-resistant major depressive disorderMichael E Thase, Sara A Corya, Olawale Osuntokun, et al.Biological Psychiatry|April 23, 2003
Assessing and interpreting treatment effects in longitudinal clinical trials with missing dataCraig H Mallinckrodt, Todd M Sanger, Sanjay Dubé, et al.The Journal of Clinical Psychiatry|December 9, 2003
Long-term antidepressant efficacy and safety of olanzapine/fluoxetine combination: a 76-week open-label studySara A Corya, Scott W Andersen, Holland C Detke, et al.Journal of Clinical Psychopharmacology|July 3, 2004
A double-blind, randomized study of olanzapine and olanzapine/fluoxetine combination for major depression with psychotic featuresAnthony J Rothschild, Douglas J Williamson, Mauricio F Tohen, et al.Journal of Affective Disorders|January 1, 2003
Olanzapine in the acute treatment of bipolar I disorder with a history of rapid cyclingTodd M Sanger, Mauricio Tohen, Eduard Vieta, et al.The Journal of Clinical Psychiatry|November 2, 2005
Olanzapine/fluoxetine combination for treatment-resistant depression: a controlled study of SSRI and nortriptyline resistanceRichard C Shelton, Douglas J Williamson, Sara A Corya, et al.Pageof 2